Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 <i>in vivo</i>-Reference-Cited by-全球学者库

Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo

Published:2023-03-03 Issue:4 Volume:31 Page:411-420
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Jiang Qingna¹²,Hu Yan³,Liu Quanyu¹²⁴,Tang Yuanling¹²,Wu Xinhua¹²,Liu Jingwen¹²,Tu Guihui¹²,Li Ge¹²,Lin Xiaoqing¹²,Qu Minghui¹²,Cai Yajuan¹²,Huang Xiuwang³,Xu Jianhua¹²,Deng Yanping⁵,Chen Zhuo⁶,Wu Lixian¹²

Affiliation:

1. Department of Pharmacology, School of Pharmacy, Fujian Medical University (FMU), Fuzhou, P.R. China

2. Fujian Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University (FMU), Fuzhou, P.R. China

3. Department of Public Technology Service Center, Fujian Medical University (FMU), Fuzhou, P.R. China

4. School of Pharmacy, Fujian Health College, Fuzhou, P.R. China

5. Department of Pharmaceutics, School of Pharmacy, Fujian Medical University (FMU), Fuzhou, P.R. China

6. State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian Academy, University of Chinese Academy of Sciences, Fuzhou, P.R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Joint Funds for the Innovation of Science and Technology of Fujian Province

Start-up Fund for Scientific Research, Fujian Medical University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2023.2185247

Reference30 articles.